Related Experiment Video
Updated: Dec 9, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Percutaneous Coronary Intervention or Surgery for Unprotected Left Main Disease: EXCEL Trial at 5 Years
Lorenzo Azzalini1, Gregg W Stone2
1The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA. Electronic address: https://twitter.com/SportsDoc2009.
Insights
Percutaneous coronary intervention is a viable alternative to coronary artery bypass graft surgery for left main disease, according to the landmark EXCEL trial. This study provides key insights into revascularization strategies.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiovascular Surgery
Background:
- Coronary artery bypass graft (CABG) surgery has been the standard for left main revascularization.
- Percutaneous coronary intervention (PCI) has advanced, offering a potential alternative.
- Left main coronary artery disease requires effective revascularization strategies.
Purpose of the Study:
- To review the background, rationale, design, results, and implications of the Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial.
- To assess the impact of different revascularization strategies for left main disease.
- To compare PCI with drug-eluting stents against CABG for left main revascularization.
Main Methods:
- The EXCEL trial is the largest contemporary randomized comparison.
- It assessed patients with left main coronary artery disease.
- The study compared PCI using the XIENCE stent with CABG.
Main Results:
- The EXCEL trial provides crucial data on the effectiveness of PCI versus CABG for left main revascularization.
- Results inform clinical decision-making for patients with left main disease.
- The trial's findings are significant for the field of interventional cardiology and cardiac surgery.
Conclusions:
- PCI is a valid alternative to CABG for a significant proportion of patients with left main disease.
- The EXCEL trial offers robust evidence to guide treatment choices.
- Understanding these revascularization strategies is essential for optimal patient outcomes.
Abstract:
Although coronary artery bypass graft (CABG) surgery traditionally has been considered the gold standard for left main revascularization, percutaneous coronary intervention has evolved in the past decades so that it now represents a valid alternative to CABG in a large proportion of cases. The landmark Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial is the largest contemporary randomized comparison assessing the impact of revascularization strategies for left main disease. This review discusses the background, rationale, design, results, and implications of the EXCEL trial.
More Related Videos
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Mitral Stenosis III: Medical Management

